HomeNewsBusinessSell Ajanta Pharma, target Rs 900: Ashish Chaturmohta

Sell Ajanta Pharma, target Rs 900: Ashish Chaturmohta

"The stock can be sold at current level and on the rise up to Rs 1,000 with a stop loss above Rs 1,030 for a target of Rs 900 levels," says Ashish Chaturmohta of Sanctum Wealth Management.

May 22, 2018 / 11:12 IST
Story continues below Advertisement
Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd.

Ashish Chaturmohta

Ajanta Pharma has formed a major bearish head and shoulders reversal pattern on its monthly chart. The price has witnessed a breakout on the downside from pattern. The volumes have been above average and price erosion in last three weeks indicating selling pressure in the stock.

Story continues below Advertisement

Weekly ADX line has turned up after being flat for the last four months indicating strength in a downtrend. The weekly MACD too has moved below neutral level of zero indicating a resumption of the downtrend. Any bounce back is a shorting opportunity in the stock.

Thus, the stock can be sold at current level and on the rise up to Rs 1,000 with a stop loss above Rs 1,030 for a target of Rs 900 levels.